Viewing Study NCT01176032

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-05-21 @ 10:13 AM
Study NCT ID: NCT01176032
Status: COMPLETED
Last Update Posted: 2014-07-24
First Post: 2010-08-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: ALiskiren or Losartan Effects on bioMARKers of Myocardial Remodeling
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypertension View
None Left Ventricle Hypertrophy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Aliskiren View
None hypertension View
None concentric LVH View
None LV remodeling View
None LVMI View
None biomarkers View
None PICP View
None CT-1 View
None MMP-1 View
None TIMP-1 View
None AnxA5 View
None Aldosterone View
None Essential hypertension with concentric left ventricle hypertrophy View